More than 2,000 Pradaxa Lawsuits Filed in the US: Now, AttorneyOne Can Provide Advice

As Reuters reported on February 13, Boehringer faces more than 2,000 US lawsuits claiming that Pradaxa caused severe and fatal bleeding. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Pradaxa: serious adverse events

Pradaxa: serious adverse events

Boehringer faces more than 2,000 US lawsuits claiming that Pradaxa caused severe and fatal bleeding

San Diego, CA (PRWEB) February 19, 2014

AttorneyOne.com, a recognized authority on law, updated the website recently and now, can actively provide an expert opinion in view of the recent news on Pradaxa lawsuits and potential Pradaxa Recall lawsuit.

As Reuters reported on February 13, Boehringer faces more than 2,000 US lawsuits claiming that Pradaxa caused severe and fatal bleeding. Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, is a new oral anticoagulant mainly used as a blood thinner for patients who are at risk for stroke or atrial fibrillation.

According to court documents, the next Status Conference in the Pradaxa Multidistrict Litigation is scheduled for March 5 (MDL No. 2385, U.S. District Court, Southern District of Illinois). In a recent Case Management Order issued on January 23, a US Judge defined the first four bellwether lawsuits in the Pradaxa Multidistrict Litigation that will go for trial.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in cases of severe complications, allegedly from Pradaxa. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Pradaxa lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

As Forbes published on January 3, the US FDA plans to perform a large new safety assessment of Pradaxa (dagibatran). The study will “assess systematically the rates of bleeding and thromboembolic outcomes associated with the use of dabigatran and warfarin for patients with atrial fibrillation using data from the FDA Mini-Sentinel Distributed Database (MSDD).”

AttorneyOne.com has further information on Pradaxa lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/02/prweb11592280.htm